Nathan Lee

Nathan Lee has an extensive work experience, beginning with founding Healthnity in 2011. Nathan then joined the Johns Hopkins-NIH Partnership Doctoral Program at The National Institutes of Health in 2012. From 2014 to 2018, they were the Co-Founder of Medssenger. During this time, they were also a Scholar at the Broad Institute of MIT and Harvard, a Fellow at Brigham and Women's Hospital, and a Fellow at Harvard Medical School. In 2018, they Co-Founded VERI Nano, a nano-biotechnology platform for big problems in different industries, which was venture-backed and won MassChallenge and Allston Venture Fund. That same year, they Co-Founded Stealth Mode, a diagnostic and therapeutic platform for chronic diseases. In 2019, they became a Venture Partner at Nextrans, one of the most active VC firms in Asia. Finally, in 2022, they became a Mentor at MassChallenge.

Nathan Lee attended Harvard Medical School and The Johns Hopkins University.